Hancock 2005.
Methods | Randomized, double‐blind, cross‐over, controlled trial | |
Participants | Inclusion criteria: confirmed diagnosis of tuberous sclerosis complex and sleep problems (Quine Sleep Index score of ≥ 6 out of a possible 8) Exclusion criteria: situational sleep disorder (a higher Quine score at home with a score of < 6 elsewhere) N: 8 (1 lost to follow‐up) M: 4; F: 3 Age: 18 months to 31 years (median age 9 years) All participants had epilepsy and on concurrent AEDs; 2 participants were well controlled All had mental retardation and behavioural difficulties Duration of the trial (including follow‐up): 6 weeks |
|
Interventions | Melatonin 5 mg vs. melatonin 10 mg (see text for more details) | |
Outcomes | Seizure frequency: 4 participants had seizures during the trial, without change in the frequency (or type) of seizures compared with the baseline period before melatonin treatment at either dose Seizure freedom: 3 participants with well‐controlled epilepsy remained seizure‐free during the trial Adverse events: none reported |
|
Notes | Seizure type was not reported Concurrent AEDs not reported Seizure diaries were used to monitor the frequency and type of seizures Reasons for lost to follow‐up (1 participant) reported |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Allocation made by the pharmacy using random number sequences |
Allocation concealment (selection bias) | Low risk | Participants received identical capsules |
Blinding (performance bias and detection bias) All outcomes | Unclear risk | Blinding not explicitly reported (insufficient information to permit judgement) |
Incomplete outcome data (attrition bias) All outcomes | Low risk | No lost to follow‐up |
Selective reporting (reporting bias) | Low risk | All data regarding outcomes of interest for this systematic review reported |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Blinding not explicitly reported (insufficient information to permit judgement) |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Blinding not explicitly reported (insufficient information to permit judgement) |